07:00 , Jun 14, 2004 |  BioCentury  |  Politics, Policy & Law

NIH: COI vs. ROI

Prompted by the House Committee on Energy and Commerce's inquiry on alleged conflicts of interest at FDA and NIH, both agencies are reviewing industrial consulting by their employees over the last five years to determine...
07:00 , Jun 4, 2004 |  BC Extra  |  Politics & Policy

FDA completes conflict of interest review

Acting FDA Commissioner Lester Crawford said the agency completed its review of all outside consulting agreements of FDA employees for the last five years and found no additional "approved outside activities of concern." The agency...
07:00 , May 18, 2004 |  BC Extra  |  Politics & Policy

House wants FDA conflict of interest review

FDA has acknowledged that it granted an employee permission to provide paid consulting services for a biotech company that the agency regulated, a congressional committee reported Tuesday. In a letter to HHS, the House Committee...
08:00 , Mar 15, 2004 |  BioCentury  |  Finance

'A' for effort

'A' for effort Company Raised Date Focus Country Investors Pedigree Biovitrum $85.0 8/1/01 Metabolic Sweden MPM Capital; Nordic Capital; Karolinska Investment Fund; ABN AMRO; Carnegie Asset Management; H&B Capital; Next Gear Spun out of Pharmacia...
08:00 , Nov 17, 2003 |  BioCentury  |  Politics, Policy & Law

Infinite innuendo

Congressional investigators last week announced they had discovered what they suggested might be a devious scheme by a prominent scientist to improperly use his authority as a government employee to collaborate with an Ivy League...
08:00 , Oct 27, 2003 |  BioCentury  |  Finance

Ebb & Flow

Aderis did not price its IPO as scheduled last week, making it the third tenuous sign at the beginning of the IPO window. The neurological company's deal is now listed as "day-to-day" on the SEC's...
07:00 , Oct 21, 2003 |  BC Extra  |  Financial News

Biospect raises $27 million, hires CEO

Biomarker company Biospect (South San Francisco, Calif.) raised $27 million in a private round. Investors included Advent Venture Partners; Prospect Venture Partners; Venrock Associates; and Versant Ventures. The company also secured investments from a number...